A comparison of different methods for including 'age at menopause' in analyses of the association between hormone replacement therapy use and breast cancer

Journal of Family Planning and Reproductive Health Care

Volumn 33, Issue 1, 2007, Pages 11-16

  Simpson, Julie A ^a   English, Dallas R ^a   MacInnis, Robert J ^a   Gertig, Dorota M ^a   Hopper, John L ^a   Giles, Graham G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Age at menopause; Hormone replacement therapy; Imputation; Missing data

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENOPAUSE;

AGE OF ONSET; AGED; BREAST NEOPLASMS; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; VICTORIA;

EID: 33846424547     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118907779399828     Document Type: Article

References (21)

1. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997; 350: 1047-1059.
2. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427.
3. Pike MC, Ross RK, Spicer DV. Problems involved in including women with simple hysterectomy in epidemiological studies measuring the effects of hormone replacement therapy on breast cancer risk. Am J Epidemiol 1998; 147: 718-721.
4. Rockhill B, Colditz GA, Rosner B. Bias in breast cancer analyses due to error in age at menopause. Am J Epidemiol 2000; 151: 404-408.
5. Lyles RH, Allen AS. Estimating crude or common odds ratios in case-control studies with informatively missing exposure data. Am J Epidemiol 2002; 155: 274-281.
6. Demissie S, LaValley MP, Horton NJ, Glynn RJ, Cupples LA. Bias due to missing exposure data using complete-case analysis in the proportional hazard regression model. Stat Med 2003; 22: 545-557.
7. Barzi F, Woodward M. Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiol 2004; 160: 34-45.
8. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002; 156: 69-70.
9. Carlin JB, Li N, Greenwood P, Coffey C. Tools for analysing multiple imputed datasets. The State Journal 2003; 3: 226-244.
10. Bhattacharya S, Mollison J, Pinion S, Parkin DE, Abramovich DR, Terry P, et al. A comparison of bladder and ovarian function two years following hysterectomy or endometrial ablation. Br J Obstet Gynaecol 1996; 103: 898-903.
11. Chalmers C, Lindsay M, Usher D, Warner P, Evans D, Ferguson M. Hysterectomy and ovarian function: levels of follicle stimulating hormone and incidence of menopausal symptoms are not affected by hysterectomy in women under age 45 years. Climacteric 2002; 5: 366-373.
12. Derksen JG, Brolmann HA, Wiegerinck MA, Vader HL, Heintz AP. The effect of hysterectomy and endometrial ablation on follicle stimulating hormone (FSH) levels up to 1 year after surgery. Maturitas 1998; 29: 133-138.
13. Bukovsky I, Halperin R, Schneider D, Golan A, Hertzianu I, Herman A. Ovarian function following abdominal hysterectomy with and without unilateral oophorectomy. Eur J Obstet Gynecol Reprod Biol 1995; 58: 29-32.
14. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987; 47: 94-100.
15. Simpson JA, MacInnis RJ, English DR, Gertig DM, Morris HA, Giles GG. A comparison of estradiol levels between women with a hysterectomy and ovarian conservation and women with an intact uterus. Climacteric 2005; 8: 300-303.
16. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-15.
17. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-1593.
18. Van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681-694.
19. Trichopoulos D, MacMahon B, Cole P. Menopause and breast cancer risk. J Natl Cancer Inst 1972; 48: 605-613.
20. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley, 1987.
21. Schafer JL. Analysis of Incomplete Multivariate Data. London, UK: Chapman & Hall, 1997.